Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC lifted its holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) by 193.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,579 shares of the company’s stock after acquiring an additional 23,442 shares during the period. SG Americas Securities LLC owned approximately 0.09% of Viemed Healthcare worth $285,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. National Bank of Canada FI grew its position in Viemed Healthcare by 91.2% in the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock valued at $25,000 after acquiring an additional 1,596 shares in the last quarter. Perkins Coie Trust Co acquired a new stake in Viemed Healthcare during the 3rd quarter valued at $73,000. PDT Partners LLC purchased a new stake in Viemed Healthcare during the 3rd quarter worth $78,000. Walleye Capital LLC purchased a new position in Viemed Healthcare in the 3rd quarter valued at about $87,000. Finally, The Manufacturers Life Insurance Company grew its stake in Viemed Healthcare by 14.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 14,918 shares of the company’s stock valued at $98,000 after purchasing an additional 1,912 shares in the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Insider Buying and Selling at Viemed Healthcare

In other Viemed Healthcare news, Director Randy E. Dobbs sold 36,261 shares of the company’s stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the transaction, the director now owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. This represents a 25.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nitin Kaushal sold 30,000 shares of the company’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $9.56, for a total transaction of $286,800.00. Following the sale, the director now directly owns 126,843 shares of the company’s stock, valued at $1,212,619.08. This represents a 19.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 72,256 shares of company stock valued at $674,739. Company insiders own 20.00% of the company’s stock.

Viemed Healthcare Stock Performance

Shares of VMD opened at $8.33 on Thursday. Viemed Healthcare, Inc. has a 12-month low of $6.21 and a 12-month high of $10.44. The business’s fifty day moving average price is $8.29 and its 200 day moving average price is $8.08. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The stock has a market capitalization of $324.37 million, a PE ratio of 30.85 and a beta of 1.45.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. The company had revenue of $58.00 million for the quarter. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.